On average, 7 out of 10 retail investors suffer losses when trading turbo certificates. Turbo certificates are highly risky products and are not suited for long-term investment strategies.
6.026 - 6.050 of 94.502
- Product
- Maturity
- Leverage (Omega)
- Sell
- Buy
- NXP Semiconductors NV Call 295,00 15 Sep 2028
- Goldman Sachs
- 15.09.28
- 2,29x
- Analysis
- Alphabet Call 250,00 16 Mar 2029
- Goldman Sachs
- 16.03.29
- 2,07x
- Analysis
- Autodesk Inc USD Call 285,00 19 Jan 2029
- Goldman Sachs
- 19.01.29
- 2,08x
- Analysis
- Colgate-Palmolive Call 106,00 19 Jan 2029
- Goldman Sachs
- 19.01.29
- 3,13x
- Analysis
- Mercadolibre Call 1.480,00 15 Sep 2028
- Goldman Sachs
- 15.09.28
- 2,17x
- Analysis
- Regeneron Pharmaceuticals Call 1.040,00 17 Dec 2027
- Goldman Sachs
- 17.12.27
- 3,49x
- Analysis
- Siemens Put 350,00 15 Dec 2028
- Goldman Sachs
- 15.12.28
- 1,35x
- Analysis
- Regeneron Pharmaceuticals Call 990,00 19 Jan 2029
- Goldman Sachs
- 19.01.29
- 2,31x
- Analysis
- Coinbase Put 80,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 1,63x
- Analysis
- Coinbase Put 80,00 17 Mar 2028
- Goldman Sachs
- 17.03.28
- 1,20x
- Analysis
- Regeneron Pharmaceuticals Call 1.020,00 17 Mar 2028
- Goldman Sachs
- 17.03.28
- 3,02x
- Analysis
- Gilead Sciences Call 195,00 15 Dec 2028
- Goldman Sachs
- 15.12.28
- 2,79x
- Analysis
- Robinhood Call 76,00 16 Jun 2028
- Goldman Sachs
- 16.06.28
- 1,88x
- Analysis
- Regeneron Pharmaceuticals Call 990,00 15 Dec 2028
- Goldman Sachs
- 15.12.28
- 2,38x
- Analysis
- Illumina, Inc. Call 245,00 19 Jan 2029
- Goldman Sachs
- 19.01.29
- 1,76x
- Analysis
- Texas Instruments Call 290,00 19 Jan 2029
- Goldman Sachs
- 19.01.29
- 2,14x
- Analysis
- Eli Lilly Put 1.600,00 17 Jun 2027
- Goldman Sachs
- 17.06.27
- 2,97x
- Analysis
- Chevron Call 270,00 17 Dec 2027
- Goldman Sachs
- 17.12.27
- 5,17x
- Analysis
- Eli Lilly Call 2.400,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 4,97x
- Analysis
- Regeneron Pharmaceuticals Call 1.050,00 15 Dec 2028
- Goldman Sachs
- 15.12.28
- 2,46x
- Analysis
- Regeneron Pharmaceuticals Call 980,00 17 Dec 2027
- Goldman Sachs
- 17.12.27
- 3,31x
- Analysis
- Altria Call 88,00 16 Jun 2028
- Goldman Sachs
- 16.06.28
- 4,48x
- Analysis
- Illumina, Inc. Call 230,00 17 Dec 2027
- Goldman Sachs
- 17.12.27
- 2,39x
- Analysis
- Regeneron Pharmaceuticals Call 1.010,00 17 Dec 2027
- Goldman Sachs
- 17.12.27
- 3,40x
- Analysis
- Altria Call 88,00 15 Dec 2028
- Goldman Sachs
- 15.12.28
- 3,74x
- Analysis